Financial Results : Twareat net profit rises to SAR 16.1M in H1 2024

Twareat net profit rises to SAR 16.1M in H1 2024

29/12/2024 Argaam Exclusive

View other reports

Twareat Medical Center (TMC), slated for direct listing on the Nomu-Parallel Market, posted SAR 16.1 million in net profit for the first half of 2024, up from SAR 6.5 million in the year-ago period.



Financials (M)

Item 6m 2023 6m 2024 Change‬
Revenues 71.70 92.23 28.6 %
Gross Income 23.58 35.20 49.3 %
Operating Income 6.62 15.88 140.0 %
Net Income 6.53 16.13 147.0 %
Average Shares 40.00 40.00 -
EPS (Riyals) 0.16 0.40 147.0 %

The first-half profit rise was driven by a 29% annual increase in the six-month revenues, coupled with the higher gross and operating profit margins.

 

In addition, EBITDA rose to SAR 17.7 million in H1 2024, from SAR 8 million in H1 2023.

 

On a biannual basis, the company’s bottom line more than doubled from SAR 7.64 million in H2 2023.



Current Half Annual Comparison (M)

Compared With The
Item H1 2023 H1 2024 Change‬
Revenues 71.70 92.23 28.6 %
Gross Income 23.58 35.20 49.3 %
Operating Income 6.62 15.88 140.0 %
Net Income 6.53 16.13 147.0 %
Average Shares 40.00 40.00 -
EPS (Riyals) 0.16 0.40 147.0 %

Shareholders’ equity amounted to SAR 60.69 million by the end of H1 2024, compared to SAR 44.34 million in H1 2023.



Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 - - - - - -
H2 2020 - - - - - -
H1 2021 - - - - - -
H2 2021 - - - - - -
H1 2022 - - - - - -
H2 2022 - - - - - -
H1 2023 71.70 - 23.58 - 6.62 -
H2 2023 83.02 - 25.55 - 7.48 -
H1 2024 92.23 28.6 % 35.20 49.3 % 15.88 140.0 %


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS Before XO Items
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 - - - - - -
H2 2020 - - - - - -
H1 2021 - - - - - -
H2 2021 - - - - - -
H1 2022 - - - - - -
H2 2022 - - - - - -
H1 2023 6.53 - 0.16 - 6.53 0.16
H2 2023 7.64 - 0.19 - 7.64 0.19
H1 2024 16.13 147.0 % 0.40 - 16.13 0.40

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 - - -
H1 2021 - - -
H2 2021 - - -
H1 2022 - - -
H2 2022 - - -
H1 2023 - - -
H2 2023 31.75 % 11.13 % 9.16 %
H1 2024 34.67 % 15.37 % 13.56 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
H1 2015 - - - -
H2 2015 - - - -
H1 2016 - - - -
H2 2016 - - - -
H1 2017 - - - -
H2 2017 - - - -
H1 2018 - - - -
H2 2018 - - - -
H1 2019 - - - -
H2 2019 - - - -
H1 2020 - - - -
H2 2020 - - - -
H1 2021 - - - -
H2 2021 - - - -
H1 2022 - - - -
H2 2022 - - - -
H1 2023 40.00 - - 1.11
H2 2023 40.00 0.35 0.35 1.29
H1 2024 40.00 0.59 0.59 1.52

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 - - -
H1 2021 - - -
H2 2021 - - -
H1 2022 - - -
H2 2022 - - -
H1 2023 - - -
H2 2023 - - -
H1 2024 - - -

Business Segments (Million)

Compared With The
Period Rural Area Unit Industrial Services Unit Medical Operations Department Tawreat Medical Center
Q2 2023 44.62 18.23 8.81 0.04
Q4 2023 42.24 21.74 18.92 0.12
Q2 2024 57.90 21.18 9.56 3.59


Share Price

Twareat Medical Center

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.